February, 2022

202202Feb18:3019:30Cancer: Modern Therapeutic Approach & Prognosis18:30 - 19:30

Cancer Modern Therapeutic Approach and Prognosis

Event Details

An Online Event

When: Wednesday, February 2, 2022, 18:30-19:30 (Greece)

Organized by: Institute of Public Health – The American College of Greece


The lecture will be held in Greek.

You can watch it here


Information: +30 210 331 4755

You can watch the videos of previous lectures here.

Speaker’s bio

Meletios Dimopoulos

Meletios-Athanasios Dimopoulos

Hematologist – Oncologist
Professor and Rector of the National & Kapodistrian, University of Athens

Meletios A. Dimopoulos, MD is Professor and Chairman of the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens School of Medicine, Athens, Greece. He has been elected Vice Dean of the Medical School for the academic years 2007-2011 and Dean for the academic years 2011-2015. In February 2015 he was elected Rector of the National and Kapodistrian University of Athens for a 4-year term. He obtained his medical degree from the National and Kapodistrian University of Athens in 1985, completed a residency in internal medicine at the Royal Victoria Hospital, McGill University, Montreal, Canada and a fellowship in hematology/oncology at the University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Dr. Dimopoulos is a member of numerous scientific societies and has authored more than 1200 publications (October 2021) in peer-reviewed journals, as well as numerous abstracts and several textbook chapters primarily focusing on plasma cell dyscrasias and genitourinary and gynecologic cancers. He has more than 79,000 citations and his h-index is 125 (Scopus) and more than 68,000 citations and an h-index 115 (ISI). He is a journal reviewer for several journals including New England Journal of Medicine, Blood, Journal of Clinical Oncology, Haematologica, Leukemia, Cancer, European Journal of Haematology, Leukemia and Lymphoma etc. Dr. Dimopoulos was Associate Editor of the European Journal of Internal Medicine (2001-2007), is an Associate Editor of Current Hematologic Malignancy Reports and is an Editorial Board Member of the Journal of Clinical Oncology (2005-2008), of Haematologica, of Leukemia and Lymphoma, of Clinical Lymphoma, Myeloma and Leukemia (2018), of Expert Review of Hematology and of Blood Advances. Dr. Dimopoulos was an elected member of the Board of the International Myeloma Society (2013-2017).

Dr. Dimopoulos serves on the Scientific Advisory Boards of the International Myeloma Foundation, of the International Waldenstrom’s Macroglobulinemia Foundation and he is a member of the Board of the European Myeloma Network. Dr. Dimopoulos organized the XIth International Myeloma Workshop and the IVrth International Workshop on Waldenstrom’s Macroglobulinemia (Kos Island, Greece June 2007). In March 2013 Dr. Dimopoulos was elected as a member of the Board of the International Myeloma Society. Currently he is the chairman of the Greek Myeloma Study Group and of the Balkan Myeloma Study Group.

He is a recipient of the Robert A. Kyle Award for outstanding contributions to Waldenstrom’s macroglobulinemia (May 2003), a recipient of Waldenstrom’s award for Myeloma Research of the International Myeloma Society (March 2017), recipient of the CoMy Excellence Award (May 2017) and of the Robert Kyle Life Achievement Award (June 2019). In August 2017 he was given the title “Officier dans l’ Ordre des Palmes academiques” (Republique Francaise, Ministere de l’ Education Nationale). In May 2018 he was elected as membre associe etranger of the National Academy of Medecine of France. In January 2020 he received the MD Anderson Distinguished Alumnus Award. In February 2020 he was awarded by the President of the Hellenic Republic with the medal of the Grand Commander of the Order of the Phoenix. Currently he is the Chairman of the Board of the Foundation of “Julia and Alexander N. Diomedes Botanic Garden” and he is a member of the Board of the National Greek Committee for UNESCO.